According to IMARC Group’s latest report, titled “Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 the global transfection technologies market is expected to reach a value of US$ 1.5 Billion by 2026, exhibiting a CAGR of more than 8% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Transfection technology refers to the artificial introduction of nucleic acids, such as Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA), and oligonucleotides, into the cells. This is done through various chemical, physical, and biological methods that enable the modification of certain cell properties. Transfection technology is commonly utilized for different genomic studies, such as gene expression, in vitro research, RNA interference, cell representation, and the bio-production of vaccines.
Request Free Sample Report: https://www.imarcgroup.com/transfection-technologies-market/requestsample
Market Trends
The high prevalence of chronic diseases, such as cancer, has augmented the demand for transfection technology. Moreover, the growing popularity of reagent-based transfection due to their cost-efficiency and less complexity is boosting the market growth. Additionally, the increasing adoption of instrument-based methods, such as biolistic technology, microinjection, laserfection, etc., is also driving the market. Moreover, several technological advancements in cell research and therapeutic discoveries further bolster the demand for transfection technology. Besides this, the rising investments by various government and private organizations to promote large scale transfection facilities is also a growth-inducing factor. In the coming years, the increasing number of R&D activities in protein therapeutics are anticipated to escalate the market growth.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/transfection-technologies-market
List of Key Companies Covered in this Market Report:
- Agilent Technologies Inc. (NYSE: A)
- Bio-RAD Laboratories Inc. (NYSE: BIO)
- Lonza Group AG (SWX: LONN)
- Maxcyte Inc. (LON: MXCT)
- Mirus Bio LLC
- Polyplus Transfection
- Promega Corporation
- Roche Holding AG (SWX: RO)
- Sigma-Aldrich Corporation
- Thermo Fisher Scientific Inc. (NYSE: TMO)
The report has segmented the market on the basis of type, service, application, transfection method, technology, end user and geography.
Breakup by Product Type:
- Reagent
- Instrument
- Others
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
- Others
Breakup by Transfection Method:
- Lipofection
- Eletroporation
- Nucleofection
- Cotransfection
- Cationic Lipid Transfection
- In-Vivo Transfection
- Others
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End-User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
